About this trial
Optimization of hemoglobin levels for organ perfusion is essential, especially in critically ill patients. Although anemia is associated with severe organ failure, especially in coronary artery disease, the effects of blood transfusion or various interventions to increase hemoglobin levels on outcomes continue to be debated. The effects of hemoglobin levels in emergency surgery patients on the development of postoperative AKI have been investigated in a small number of studies in the literature, and clear results have not yet been reported. This study was designed to evaluate the effect of hemoglobin levels on the development of AKI after adjustment for known predictive factors.
Eligibility criteria
Qualifiers
Patients undergoing emergency non-cardiac surgery
Disqualifiers
Known renal failure
Need for reoperation within 48 hours postoperatively
Exit status within 48 hours postoperatively
Known hematological disease
Trial design
Treatments tested in this trial
- Observational